Task: Answer the multiple-choice question.
Question: Which compound exhibits a 8.423% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a) CN1CCN(Cc2ccc(Br)s2)CC1
b) COCCN(Cc1nc(-c2ccc(-c3ccccc3)cc2)oc1C)C(C)C
c) Cc1c(O)cc2n(c1=O)-c1ccccc1C2(C)C
d) Nc1nnc(SCc2cccnc2)s1
Answer: a. CN1CCN(Cc2ccc(Br)s2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN1CCN(Cc2ccc(Br)s2)CC1
CN1CCN(Cc2ccc(Br)s2)CC1
4-[(5-bromothiophen-2-yl)methyl]-1-methylpiperazine